Literature DB >> 23746540

Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotype.

Charlotte Nymberg1, Tianye Jia, Steven Lubbe, Barbara Ruggeri, Sylvane Desrivieres, Gareth Barker, Christian Büchel, Mira Fauth-Buehler, Anna Cattrell, Patricia Conrod, Herta Flor, Juergen Gallinat, Hugh Garavan, Andreas Heinz, Bernd Ittermann, Claire Lawrence, Karl Mann, Frauke Nees, Angelica Salatino-Oliveira, Marie-Laure Paillère Martinot, Tomas Paus, Marcella Rietschel, Trevor Robbins, Michael Smolka, Tobias Banaschewski, Katya Rubia, Eva Loth, Gunter Schumann.   

Abstract

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is characterized by deficits in reward sensitivity and response inhibition. The relative contribution of these frontostriatal mechanisms to ADHD symptoms and their genetic determinants is largely unexplored.
METHODS: Using functional magnetic resonance imaging and genetic analysis of the monoamine oxidase A (MAOA) gene, we investigated how striatal and inferior frontal activation patterns contribute to ADHD symptoms depending on MAOA genotype in a sample of adolescent boys (n = 190).
RESULTS: We demonstrate an association of ADHD symptoms with distinct blood oxygen level-dependent (BOLD) responses depending on MAOA genotype. In A hemizygotes of the expression single nucleotide polymorphism rs12843268, which express lower levels of MAOA, ADHD symptoms are associated with lower ventral striatal BOLD response during the monetary incentive delay task and lower inferior frontal gyrus BOLD response during the stop signal task. In G hemizygotes, ADHD symptoms are associated with increased inferior frontal gyrus BOLD response during the stop signal task in the presence of increased ventral striatal BOLD response during the monetary incentive delay task.
CONCLUSIONS: Depending on MAOA genotype, ADHD symptoms in adolescent boys are associated with either reward deficiency or insufficient response inhibition. Apart from its mechanistic interest, our finding may aid in developing pharmacogenetic markers for ADHD. Crown
Copyright © 2013 Published by Elsevier Inc on behalf of Society of Biological Psychiatry. All rights reserved.

Entities:  

Keywords:  Attention-deficit/hyperactivity disorder; genetics; inferior frontal gyrus; monoamine oxidase A; neuroimaging; ventral striatum

Mesh:

Substances:

Year:  2013        PMID: 23746540     DOI: 10.1016/j.biopsych.2013.03.027

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

Review 1.  Applying imaging genetics to ADHD: the promises and the challenges.

Authors:  Zhaomin Wu; Li Yang; Yufeng Wang
Journal:  Mol Neurobiol       Date:  2014-04-01       Impact factor: 5.590

2.  Disrupted brain functional networks in drug-naïve children with attention deficit hyperactivity disorder assessed using graph theory analysis.

Authors:  Ying Chen; Xiaoqi Huang; Min Wu; Kaiming Li; Xinyu Hu; Ping Jiang; Lizhou Chen; Ning He; Jing Dai; Song Wang; Manxi He; Lanting Guo; John A Sweeney; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2019-07-30       Impact factor: 5.038

3.  Prenatal iron deficiency and monoamine oxidase A (MAOA) polymorphisms: combined risk for later cognitive performance in rhesus monkeys.

Authors:  Mari Golub; Casey Hogrefe
Journal:  Genes Nutr       Date:  2014-01-09       Impact factor: 5.523

4.  Reward Processing in Drug-Naive Youth with Various Levels of Risk for Substance Use Disorders: A Pilot Study.

Authors:  Iliyan Ivanov; Kurt Schulz; Xiaobo Li; Jeffrey Newcorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-06-10       Impact factor: 2.576

Review 5.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

6.  Effect of brain structure and function on reward anticipation in children and adults with attention deficit hyperactivity disorder combined subtype.

Authors:  Viola Kappel; Robert C Lorenz; Martina Streifling; Babette Renneberg; Ulrike Lehmkuhl; Andreas Ströhle; Harriet Salbach-Andrae; Anne Beck
Journal:  Soc Cogn Affect Neurosci       Date:  2014-10-22       Impact factor: 3.436

Review 7.  Biomarkers in the diagnosis of ADHD--promising directions.

Authors:  Stephen V Faraone; Cristian Bonvicini; Catia Scassellati
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

Review 8.  The role of monoamine oxidase A in aggression: Current translational developments and future challenges.

Authors:  Sean C Godar; Paula J Fite; Kenneth M McFarlin; Marco Bortolato
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-01-09       Impact factor: 5.067

9.  Separate neural systems for behavioral change and for emotional responses to failure during behavioral inhibition.

Authors:  Wanlu Deng; Edmund T Rolls; Xiaoxi Ji; Trevor W Robbins; Tobias Banaschewski; Arun L W Bokde; Uli Bromberg; Christian Buechel; Sylvane Desrivières; Patricia Conrod; Herta Flor; Vincent Frouin; Juergen Gallinat; Hugh Garavan; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Herve Lemaitre; Frauke Nees; Dimitri Papadopoulos Orfanos; Luise Poustka; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Jianfeng Feng
Journal:  Hum Brain Mapp       Date:  2017-04-21       Impact factor: 5.038

10.  DRD2/ANKK1 polymorphism modulates the effect of ventral striatal activation on working memory performance.

Authors:  Charlotte Nymberg; Tobias Banaschewski; Arun L W Bokde; Christian Büchel; Patricia Conrod; Herta Flor; Vincent Frouin; Hugh Garavan; P Gowland; Andreas Heinz; Bernd Ittermann; Karl Mann; Jean-Luc Martinot; Frauke Nees; Tomas Paus; Zdenka Pausova; Marcella Rietschel; Trevor W Robbins; Michael N Smolka; Andreas Ströhle; Gunter Schumann; Torkel Klingberg
Journal:  Neuropsychopharmacology       Date:  2014-04-09       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.